About this trial
The neural basis of auditory hallucinations (AH) in patients with schizophrenia is poorly characterized. Functional imaging studies investigate either the "state" dimension (i.e., the measurement of changes in brain area activation at the precise moment of AH onset) or the "trait" dimension (i.e., the neural correlates of the propensity to hallucinate). A corollary of AH (particularly acoustic-verbal) is the activation of brain regions involved in the auditory perception of speech (auditory cortex). One theory is that patients with schizophrenia with AH may have a deficit in processing their internal speech (i.e., external attribution to internal verbal content). However, there is little clinical data on the specific role of the mesencephalic region of the inferior colliculi (IC) in the formation of these symptoms. Preliminary research has shown intense expression of dopamine D2 receptors, particularly on glutamatergic neurons in mouse ICs. Thus, ICs receive numerous inhibitory dopaminergic inputs, likely involved in signal optimization and modulation. The study authors hypothesize that AHs are the result of a defect in signal inhibition by the IC, which lose their function as perceptual filters.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The patient must have given their free and informed consent and signed the consent form
The patient must be a member or beneficiary of a health insurance plan
DSM-5 diagnosis of schizophrenic disorder (based on clinical assessment and confirmed by the MINI 7.0 interview)
Patient with a schizophrenic disorder lasting ≤ 20 years
Disqualifiers
The patient is under safeguard of justice or state guardianship
Contraindications to magnetic resonance imaging, including severe claustrophobia, based on clinical judgment.
Congenital or acquired deafness
Suicide risk, based on clinical judgment
Trial design
Parallel
Treatments tested in this trial
Unenhanced brain MRI
Other interventionUnenhanced brain MRI in five sequences: 1) T1-weighted anatomical sequences 2) Resting-state functional sequences 3) Task-based functional sequence 4) Structural sequence using Diffusion Tensor Imaging (DTI) 5) Routine magnetic resonance spectroscopy sequence
Treatment groups
Trial outcomes
Primary outcomes
Resting state of functional connectivity of the inferior colliculi region with other regions of the auditory network between groups
Measured by MRI
Default mode network patterns between groups
Measured by MRI
Secondary outcomes
Neuronal activation in the ICs during exposure to auditory stimuli between groups
Difference in the blood-oxygen level dependent (BOLD) signal measured by functional MRI during an auditory stimulus exposure paradigm in the IC region
Per-auditory activation in other brain areas between groups
Difference in the BOLD signal measured by functional MRI in other brain areas
IC metabolite composition between the groups
Difference in the peak magnetic resonance spectrometry (sMRI) signal
Structural connectivity via white matter between ICs and other auditory network structures between groups
Difference in structural connectivity using DTI (diffusion tensor imaging, anisotropy fraction calculation, mean diffusivity, and tractography) from the ICs
Sponsors and contacts
Click on the lead sponsor to view all of their trials.